ResearcherFred and Pamela Buffett Cancer CenterNo recent work listed
Bradley R. Hall
Matched on ORCID iD 0000-0002-1627-3340; OpenAlex author ID A5047959565. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2017: 1 paper · 2018: 2 papers · 2019: 1 paper
Papers 4
- Factors Predictive of Reoperation After Pancreaticoduodenectomy for Pancreatic Cancer. Co-author DOI 10.1007/s13193-019-00913-w↗
- Desmoplasia in pancreatic ductal adenocarcinoma: insight into pathological function and therapeutic potential. Co-author DOI 10.18632/genesandcancer.171↗
- Advanced pancreatic cancer: a meta-analysis of clinical trials over thirty years. Co-author DOI 10.18632/oncotarget.25036↗
- MUC4 mucin- a therapeutic target for pancreatic ductal adenocarcinoma. Co-author DOI 10.1080/14728222.2017.1323880↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Andrew C. Cannon · 3 shared papers, 2017–2018 · strength 0.25
- Paper Desmoplasia in pancreatic ductal adenocarcinoma: insight into pathological function and therapeutic potential. DOI 10.18632/genesandcancer.171↗
- Paper Advanced pancreatic cancer: a meta-analysis of clinical trials over thirty years. DOI 10.18632/oncotarget.25036↗
- Paper MUC4 mucin- a therapeutic target for pancreatic ductal adenocarcinoma. DOI 10.1080/14728222.2017.1323880↗
- Surinder K. Batra · 3 shared papers, 2017–2018 · strength 0.25
- Paper Desmoplasia in pancreatic ductal adenocarcinoma: insight into pathological function and therapeutic potential. DOI 10.18632/genesandcancer.171↗
- Paper Advanced pancreatic cancer: a meta-analysis of clinical trials over thirty years. DOI 10.18632/oncotarget.25036↗
- Paper MUC4 mucin- a therapeutic target for pancreatic ductal adenocarcinoma. DOI 10.1080/14728222.2017.1323880↗
- Sushil Kumar K · 3 shared papers, 2017–2018 · strength 0.25
- Paper Desmoplasia in pancreatic ductal adenocarcinoma: insight into pathological function and therapeutic potential. DOI 10.18632/genesandcancer.171↗
- Paper Advanced pancreatic cancer: a meta-analysis of clinical trials over thirty years. DOI 10.18632/oncotarget.25036↗
- Paper MUC4 mucin- a therapeutic target for pancreatic ductal adenocarcinoma. DOI 10.1080/14728222.2017.1323880↗
- Chandrakanth Are · 2 shared papers, 2018–2019 · strength 0.20
- Lynette M. Smith · 2 shared papers, 2018–2019 · strength 0.20
- Maneesh Jain · 2 shared papers, 2017–2018 · strength 0.17
- Richard L. Sleightholm · 1 shared paper, 2019 · strength 0.12
- Christopher M. Thompson · 1 shared paper, 2018 · strength 0.10
- Pranita Atri · 1 shared paper, 2018 · strength 0.08
- Apar Kishor Ganti · 1 shared paper, 2018 · strength 0.08
- Shailendra Kumar Gautam · 1 shared paper, 2017 · strength 0.07
- Rakesh Bhatia · 1 shared paper, 2017 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.